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Abstract 
Background: Unsafe abortion remains a leading cause of maternal mortality globally. Many factors can influence 
women’s decisions around where to seek abortion care; however, little research has been done on abortion care deci-
sions at a population-level in low-resource settings, particularly where abortion is legally restricted.
Methods: This analysis uses data from a 2019–2020 follow-up survey of 1144 women in six Nigerian states who 
reported an abortion experience in a 2018 cross-sectional survey. We describe women’s preferred and actual pri-
mary abortion care provider/location by distinguishing clinical, pharmacy/chemist, or other non-clinical providers or 
locations. We also examine factors that influence women’s decisions about where to terminate their pregnancy and 
identify factors hindering women’s ability to operationalize their preferences. We then examine the characteristics of 
women who were not able to use their preferred provider/location.
Results: Non-clinical providers (55.0%) were more often used than clinical providers (45.0%); however, clinical provid-
ers were preferred by most women (55.6%). The largest discrepancies in actual versus preferred abortion provider/
location were private hospitals (7.6% actual versus 37.2% preferred), government hospitals (4.3% versus 22.6%), 
chemists (26.5% versus 5.9%) and pharmacies (14.9% versus 6.6%). “Privacy/confidentiality” was the most common 
main reason driving women’s abortion provider/location choice (20.7%), followed by “convenience” (16.9%) and 
“recommended” by someone (12.3%), most often a friend (60.8%), although top reasons differed by type of provider/
location. Cost and distance were the two most common reasons that women did not use their preferred provider/
location (46.1% and 21.9%, respectively). There were no statistically significant differences in the sociodemographic 
characteristics between women who were able to use their preferred provider/location and those who were not able 
to implement their preferred choice, with the exception of state of residence.
Conclusions: These findings provide insights on barriers to abortion care in Nigeria, suggesting discretion is key to 
many women’s choice of abortion location, while cost and distance prevent many from seeking their preferred care 
provider/location. Results also highlight the diversity of women’s abortion care preferences in a legally restrictive 
environment.
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Introduction
Unsafe abortion remains a leading cause of maternal 
mortality, contributing to 8–15% of maternal deaths 
globally [1, 2]. While abortion rates do not vary widely 
by geographic setting, abortion safety is greatly impacted 
by the legal environment [3]. Legal restrictions not only 
inhibit access to safe methods and skilled care but may 
also delay care-seeking and impede access to accurate 
information and post abortion care (PAC) for treatment 
of complications [4]. Most abortions worldwide take 
place in legally restrictive settings, thus despite the high 
safety profile of abortion when done in accordance with 
medical standards [5], unsafe abortion remains a signifi-
cant threat to maternal health.
In recent years, abortion safety in legally restrictive set-
tings has improved with increased access to safe, effective 
abortion medications like Misoprostol at the community 
level [6]. As safe abortion methods become more acces-
sible, exploring the broader aspects of quality of abortion 
care is necessary to improve service delivery and reduce 
disparities in abortion outcomes. Even in legally restric-
tive settings, women may be able to exercise a degree 
of choice in determining their abortion care and many 
factors can influence women’s decisions around where 
to seek services; however, little research has been done 
on abortion care decision-making at a population level 
in low-resource settings, particularly where abortion is 
legally restricted.
In Nigeria, induced abortion is legal only to save the 
woman’s life, and in Lagos state to preserve the woman’s 
life and physical health [7, 8]; nonetheless it is a com-
mon reproductive health experience. Recent estimates 
using indirect confidante methodology indicate the one-
year abortion incidence was approximately 46 per 1000 
women aged 15 to 49 years in 2017 [9]. With unmet con-
traceptive need at 19% among married women of repro-
ductive age and 48% among unmarried sexually active 
women [10], women who find themselves pregnant at a 
time when they do not desire a child may seek out abor-
tion services despite legal restrictions. Nearly two-thirds 
of abortions are considered most unsafe, involving non-
recommended methods (i.e., methods other than sur-
gery or medication abortion drugs) from non-clinical 
providers [11]. Unsafe abortion contributes to Nigeria’s 
high maternal mortality ratio, estimated at 512 maternal 
deaths per 100,000 live births [10]. Better understanding 
women’s abortion care-seeking and associated decision-
making in this setting can inform harm reduction efforts 
that seek to reduce morbidity and mortality due to unsafe 
abortion.
In Nigeria, safe abortion options are available, largely 
a result of increased availability of medication abortion 
drugs (Mifepristone and Misoprostol) in recent years. 
Mifepristone was registered for use in 2017 and Mis-
oprostol has been on the country’s Essential Medicines 
List for incomplete and spontaneous abortion since 
2010 [12, 13]. While there is limited data on the use of 
medication abortion drugs in Nigeria, a recent review of 
referral hospital medical record data showed an increase 
in Misoprostol use for induced abortions over a nine-
year study period, and this was associated with a reduc-
tion in severe morbidity [14]. Women increasingly have 
an option to self-manage their abortion by purchasing 
the drugs through pharmacies, chemist shops, or for-
mal harm reduction efforts—like abortion hotlines and 
accompaniment models—that support women in safely 
inducing using medication abortion drugs [15, 16]. For 
facility-based care, evidence suggests that provision 
Plain language summary 
Many factors influence a woman’s pathway to obtaining an abortion, even in a setting with strict laws prohibiting the 
practice. This study aims to explore where women in Nigeria would prefer to and actually obtain their abortions, rea-
sons why they could or could not use their preferred provider/location, and differences between women who were 
and were not able to use their preferred provider/location.
The findings show that most women would opt to use a clinical source, such as a government or private hospital, 
especially among women who did not use their preferred source. Privacy/confidentiality, convenience, and recom-
mendation from someone like a friend or partner drove women’s abortion care preferences, although these influ-
ences differed by type of provider/location (clinical, pharmacy/chemist, or other non-clinical). Issues like cost, dis-
tance, and lack of privacy were barriers that prevented women from using their preferred provider/location, instead 
obtaining their abortion from a less desired provider. However, the sociodemographic characteristics of women who 
did and did not use their preferred provider/location did not differ significantly, except by state.
These findings provide insights on barriers to safe abortion care in Nigeria, suggesting social safety drives many 
women to seek care outside of the healthcare system, while cost and distance prevented many from seeking clinical 
services. Results also highlight the diversity of women’s abortion preferences in a setting where abortion is legally 
restricted.
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of abortion in facilities is not uncommon, with 38% of 
women reporting use of a private or public facility to ter-
minate their pregnancy in a recent study [11]. Thus, it is 
clear that some women are better able to navigate bar-
riers to safe abortion methods in this legally restricted 
setting.
Women’s decisions regarding where to seek abortion 
care are influenced by a number of factors. Coast et  al. 
developed a comprehensive framework that encom-
passes the full range of factors that shape women’s abor-
tion care-seeking trajectories [17], which includes the 
abortion-specific context, women’s individual context, 
and the international or sub-national context, which have 
thus far primarily been examined qualitatively or among 
PAC patients [18–20]. Studies have found that perceived 
or actual illegality of abortion and poor provider atti-
tudes deterred many women from seeking abortions in 
formal healthcare settings [21]. Awareness of and trust 
in abortion care options are also informed by women’s 
social networks [21, 22]. Financial considerations are a 
significant factor in women’s abortion care decision-mak-
ing [20, 22, 23]. Level of discretion afforded by a given 
provider also factors prominently due to the stigma of 
abortion even in legally enabling environments [22, 24]. 
Because much of this research examines the experiences 
of PAC patients within the formal healthcare system or 
among smaller qualitative samples, we lack a broader 
perspective on the factors that influence non-clinical 
abortion care decisions for women who do not present 
for care at a formal facility for a legal abortion or PAC 
and the reasons driving these decisions.
To address this knowledge gap, our study explores one 
facet of abortion care-seeking trajectories among Nige-
rian women who terminated a pregnancy in the formal or 
informal sector. The primary aim of this study is to exam-
ine the factors that influenced women’s decisions about 
where to terminate their pregnancy and their corre-
sponding preferences regarding abortion provider/loca-
tion. The secondary aim is to examine the reasons that 
hindered women’s ability to operationalize their prefer-
ence and to compare characteristics of women who were 
able and unable to use their preferred abortion provider.
Methods
Study design
This analysis uses data from two quantitative surveys 
conducted in 2018 and 2019–2020 in Nigeria by Perfor-
mance Monitoring for Action (PMA), which is imple-
mented by the Centre for Research, Evaluation Resources 
and Development (CRERD) with technical guidance pro-
vided by the Gates Institute for Population and Repro-
ductive Health at the Johns Hopkins Bloomberg School 
of Public Health. PMA currently conducts nationally or 
regionally representative surveys on family planning and 
reproductive health in nine countries in Africa and Asia. 
The 2018 PMA survey in Nigeria, conducted in April and 
May 2018, was a cross-sectional survey of households 
and eligible women aged 15–49  years in seven states 
(Anambra, Kaduna, Kano, Lagos, Nasarawa, Rivers, and 
Taraba). Details about the 2018 PMA Nigeria survey 
methodology have been published elsewhere [9]. Women 
who reported having done something to remove a preg-
nancy or bring back a period when they were worried 
they were pregnant in the 2018 survey were asked a series 
of questions about that experience and if they could be 
re-contacted for a follow-up survey.
The follow-up survey, which collected more detailed 
information on the woman’s previously reported abor-
tion experience, was conducted in December 2019 
through February 2020 with consented respondents in 
six of the seven states from baseline (there were very few 
abortions reported in Kano, thus we chose to exclude 
these respondents for practical considerations). A total 
of 1476 women were eligible and willing to be contacted 
for the follow-up survey and 1144 completed it (response 
rate: 77.5%). If the woman provided a follow-up phone 
number at baseline, study staff attempted to contact her 
by phone to remind her about her participation in the 
previous PMA survey round and willingness to be re-
contacted. If the woman was interested in participating, 
the staff arranged an interview date, time and location 
of the woman’s choosing. For women who did not pro-
vide a phone number or in cases where study personnel 
were unable to reach the woman at the number pro-
vided, PMA resident interviewers returned to the wom-
an’s community from the previous round to describe the 
study and ask about participation in person.
All respondents provided verbal informed consent 
before both the baseline and follow-up surveys to par-
ticipate. Interviews were conducted face-to-face by PMA 
interviewers in primarily Hausa, Igbo, Pidgin, Yoruba, 
or English. Surveys were professionally translated into 
Hausa, Igbo, Pidgin, and Yoruba from English and piloted 
with native speakers before data collection. Surveys were 
programmed into smart phones using OpenDataKit 
software. Ethical approval was obtained from the Johns 
Hopkins Bloomberg School of Public Health Institutional 
Review Board and the National Health Research Ethics 
Committee of Nigeria.
Measures
The baseline survey allowed respondents to report either 
a pregnancy removal or period regulation and the follow-
up survey asked about the experience using the language 
previously reported by the respondent. We refer to both 
experiences (removing a pregnancy and bringing back a 
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period) as abortions in this analysis. Women could report 
up to two abortion methods and providers/locations 
(first and last) if they reported doing multiple things to 
end the pregnancy. Follow-up survey questions focused 
on the woman’s experiences using her first (if multiple) or 
only (if one) method and provider/location; the measures 
in this analysis focus on the woman’s first/only provider/
location and the associated decision-making.
In this analysis, we classify abortion providers/loca-
tions as clinical or non-clinical. Clinical provider/loca-
tions include government hospitals, government health 
centers, family planning clinics, mobile clinics (public), 
private hospitals, private doctors, and mobile clinics (pri-
vate). Non-clinical provider/locations include pharma-
cies, chemists (drug shops not operated by pharmacists), 
public events, fieldworkers (private), shops, friends/rela-
tives, healers, markets, and other. Missing values for first/
only provider/location responses (n = 13) were classified 
as other.
We examined several respondent sociodemographic 
characteristics in this analysis, including a number of 
the woman’s characteristics at the time of her abor-
tion, specifically age (categorical), marital status, school 
attendance, whether she had any children, and rural/
urban residence. We were unable to collect information 
on women’s wealth and state of residence at the time of 
abortion; therefore, we rely on these measures at the time 
of women’s baseline survey.
Analysis
We first used descriptive statistics to examine the soci-
odemographic characteristics, preferred and actual first/
only abortion provider/location, and reasons for using 
the first/only provider/location among all women in the 
sample. We also examined the reasons for not using a 
preferred first/only provider/location among the subset 
of women who reported that they did not use their pre-
ferred provider/location. We explored differences in top 
decision-making factors by category of first/only pro-
vider/location and differences in sociodemographic char-
acteristics between women who did and did not use their 
preferred provider/location, assessed via design-based 
F-statistic. The design weights represent the inverse of 
the probability of selection multiplied by the inverse of 
the cluster response rate. We multiplied these weights 
with the loss to follow-up weights, which we calculated 
by regressing the sociodemographic characteristics of 
women who reported an abortion in the baseline sur-
vey on their odds of completing the follow-up survey 
and taking the inverse of the predicted probability from 
that model. All analyses were conducted using Stata 15.1 
(College Station, TX).
Results
The sociodemographic characteristics of follow-up inter-
view participants at the time of their abortion experience 
are presented in Table  1. At the time of their abortion, 
most women were under the age of 30 years and at peak 
childbearing: 2.8% were under 15  years, 18.3% were 
15–19  years, 29.2% were 20–24  years, and 22.0% were 
25–29 years. Over half of women were married (53.0%), 
Table 1 Background characteristics of respondents at time of 
abortion (N = 1144)*
*Ns across categories of a characteristic that do not sum to total N is a result of 
missingness
^From time of baseline survey, not time of abortion
n (%)
Age
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28.8% were attending school, 48.6% had children, and 
69.0% were living in an urban setting.
Women were asked for both their actual and preferred 
first/only provider/location for their abortion. Broadly, 
non-clinical providers (55.0%) were more often used 
than clinical providers (45.0%); however, clinical provid-
ers were preferred by most women (55.6%) (Table 2). The 
most frequently used and preferred individual provider, 
among both clinical and non-clinical providers, was a 
private hospital, which was the first/only provider used 
by 25.7% of women and preferred by 31.2%. Chemists 
(17.3%) and pharmacies (12.8%), classified as non-clinical 
providers, were the next most commonly used provid-
ers and were preferred by 13.5% and 11.3% of women, 
respectively.
Table 3 presents reasons why women chose their first/
only abortion provider/location and the primary deci-
sion-making factor, overall and by provider type (clinical, 
pharmacy/chemist, and other non-clinical). Convenience 
(41.1%), privacy/confidentiality (39.7%), location (28.9%), 
and cost (24.3%) were the most common reasons driv-
ing provider choice overall, but when selecting the top 
reason, privacy/confidentiality was the most common, 
reported by one-fifth of women, followed by convenience 
(16.9%) and recommended by someone (12.3%), most 
often by a friend (60.8%). The top reason varied by the 
type of provider. Women who first sought care from a 
clinical provider were significantly more likely to cite that 
their top reason was recommended by someone (16.1%) 
or that the provider had a good reputation (17.5%) com-
pared to those who went to a pharmacy/chemist (10.0% 
recommended; 6.1% good reputation) or to those who 
sought care from other non-clinical providers (8.2% 
recommended; 2.6% good reputation). Those who first 
sought care at a pharmacy/chemist shop or relied on 
other non-clinical providers were significantly more 
likely to cite cost as their top reason (12.6% and 16.2%, 
respectively) compared with women who sought care 
from a clinical provider (5.8%). Additionally, women who 
sought care at a pharmacy/chemist and who indicated 
that their main reason was a recommendation were more 
likely to report that the recommender was a healthcare 
provider (19.5%) than those who went to clinical provid-
ers (5.5%) or to other non-clinical providers (0.0%).
Table 4 shows the actual and preferred first/only pro-
vider/location for the subset of women who reported that 
they did not use their preferred provider. Of the 1144 
women interviewed at follow-up, 255 (22.3%) reported 
that they would have preferred to go to a different pro-
vider than the first/only provider that they used. Among 
this group of women, 81.0% sought care from a non-clin-
ical provider like a chemist (26.5%) or pharmacy (14.9%), 
and 19.0% sought care from a clinical provider; however, 
over three-quarters (77.4%) would have preferred a clini-
cal provider. The largest discrepancies in actual versus 
preferred abortion provider/location were private hos-
pital (7.6% actual versus 37.2% preferred), government 
hospital (4.3% versus 22.6%), chemist (26.5% versus 
5.9%) and pharmacy (14.9% versus 6.6%). Women most 
often reported that cost was the reason that they did not 
use their preferred source (46.1%); the next most com-
mon reasons were distance from the provider (21.9%), 
inconvenient (16.0%), and not private (12.9%) (Table  5). 
Bivariate analysis of sociodemographic characteristics 
at the time of their abortion comparing women who did 
and did not use their preferred provider/location found 
no statistically significant differences between these two 
groups, except by state (Table 6).
Discussion
Our study contributes new findings on abortion care-
seeking among a general population of women in Nige-
ria, showing that most women in Nigeria prefer clinical 
sources of care. While more than half of women rely on 
non-clinical providers, many are able to achieve their 
provider preferences including accessing clinical care. 
These results expand on prior research which mostly 
relies on samples of PAC patients presenting at tertiary 
facilities, showing 57% of women used doctors/nurses as 
their abortion provider in one study compared to 8% in 
Table 2 Actual first/only abortion provider and preferred 
provider among all respondents (N = 1144)
Actual source Preferred source
n (%) n (%)
Clinical sources 483 (45.0) 637 (55.6)
Government hospital 85 (7.3) 155 (10.6)
Government health center 30 (2.2) 55 (3.5)
Family planning clinic 1 (0.1) 5 (0.3)
Mobile clinic (public) 1 (0.2) 1 (0.2)
Private hospital 265 (25.7) 315 (31.1)
Private doctor 98 (9.3) 103 (9.7)
Mobile clinic (private) 3 (0.3) 3 (0.3)
Non-clinical sources 661 (55.0) 507 (44.4)
Pharmacy 128 (12.8) 106 (11.3)
Chemist 208 (17.3) 157 (13.5)
Public event 1 (0.1) 1 (0.1)
Fieldworker (private) 8 (0.8) 6 (0.6)
Shop 53 (5.0) 38 (3.7)
Friend/relative 27 (2.4) 23 (2.0)
Healer 67 (4.1) 50 (3.5)
Market 96 (7.1) 68 (5.2)
Other 60 (4.6) 44 (3.3)
Do not know/no response 13 (0.9) 14 (1.2)
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another that also found nearly half of women went to a 
non-clinical “quack” [25, 26]. We found more diversified 
sources of care—45% clinical providers, 30% pharmacies/
chemists, and 25% other non-clinical—among a broader 
population of women and furthermore explored reasons 
and barriers to accessing preferred care.
Privacy and convenience were the top factors for 
choosing a provider, which aligns with qualitative 
research that has noted the importance of discretion and 
safety from social stigma to women when choosing an 
abortion provider [22, 23, 27, 28]. While women’s abil-
ity to operationalize their care preferences did not differ 
significantly by their sociodemographic characteristics, 
cost was an important reason why women opted for a 
non-clinical provider and the main barrier for not using 
their preferred method, followed by distance. This may 
point to socioeconomic inequities in women’s ability to 
access safe abortion methods, which is consistent with 
other research findings [9, 29]. These factors signal the 
influence of wealth and residence as contributions to dis-
parities seen in abortion outcomes, where poor and rural 
women are most likely to have an unsafe abortion and 
least likely to seek care for complications [29].
Abortion legality in Nigeria varies by state. In Lagos 
state, abortion is legal to preserve the life and physical 
health of the woman [7, 8], compared to all other states 
where abortion is only legal to preserve the woman’s life. 
The legal environment may impact a woman’s access to 
clinical care by state, which represented 56.3% of abor-
tion care in Lagos but only 30.4% in Taraba. However, 
these legal restrictions are more likely to inform wom-
en’s preferences rather than their ability to achieve their 
preferences, as we found no statistically significant dif-
ferences between women who used their preferred 
provider/location and those who did not by state when 
accounting for other sociodemographic characteristics. 
Additional research could provide greater insight on the 
legal conditioning of women’s decisions in abortion care 







factor among all 
respondents
Top decision-making 
factor among users 
of clinical sources 
(n = 483)
Top decision-making 




factor among users 
of other non-clinical 
sources* (n = 325)
p-value
n (%) n (%) n (%) n (%) n (%)
Cost 305 (24.3) 128 (10.4) 29 (5.8) 46 (12.6) 53 (16.2)  < 0.001
Convenience 479 (41.1) 188 (16.9) 74 (16.0) 55 (16.8) 59 (18.5) 0.762
Location 390 (28.9) 122 (9.2) 47 (7.3) 37 (10.5) 38 (11.2) 0.212
Privacy/confidentiality 474 (39.7) 254 (20.7) 107 (18.6) 81 (23.7) 66 (20.8) 0.319
Method offered 190 (14.3) 57 (4.1) 26 (4.5) 18 (4.0) 13 (3.2) 0.686
Recommended 237 (22.3) 114 (12.3) 62 (16.1) 29 (10.0) 23 (8.2) 0.017
 Partner 84 (29.3) 24 (18.6) 16 (22.9) 5 (16.9) 3 (6.1) 0.311
 Family member 25 (12.2) 8 (7.8) 5 (8.2) 1 (4.7) 2 (11.2) 0.743
 Friend 117 (55.1) 63 (60.8) 34 (59.8) 15 (56.8) 14 (70.1) 0.729
 Health provider 21 (7.6) 9 (8.0) 4 (5.5) 5 (19.5) 0 (0.0) 0.053
 Community health 
worker
9 (2.6) 6 (3.6) 5 (5.5) 1 (1.4) 0 (0.0) 0.324
 Pharmacist 16 (1.0) 1 (0.1) 0 (0.0) 1 (0.4) 0 (0.0) 0.673
 Online resources 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) –
 Hotline (phone 
numbers)
0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) –
 Other 7 (2.8) 4 (2.1) 0 (0.0) 0 (0.0) 4 (12.5) 0.010
Provider had good 
reputation
236 (21.5) 109 (10.4) 81 (17.5) 19 (6.1) 9 (2.6)  < 0.001
Knew provider 134 (12.6) 51 (5.7) 28 (6.7) 13 (5.2) 10 (4.3) 0.594
Only option knew of 
nearby
99 (9.1) 49 (4.7) 13 (3.7) 19 (6.4) 17 (4.3) 0.348
Other 8 (1.1) 8 (1.1) 5 (1.9) 2 (0.4) 1 (0.4) 0.066
Do not know/no 
response
0 (0.0) 64 (4.7) 11 (1.8) 17 (4.2) 36 (10.4) –
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at the subnational level within Nigeria, a populous, het-
erogeneous country.
While harm reduction models that allow women to 
safely induce outside the formal healthcare system are 
increasingly being examined and promoted [30, 31], this 
analysis shows that most women seeking abortion in 
Nigeria would prefer to seek clinical care, such as hospi-
tals, for safe abortion. Although provider bias and stigma 
are persistent issues [32, 33], women seeking abortion 
and PAC in other settings have reported confidence and 
satisfaction with services provided at upper-level clinical 
facilities [34]. Other factors like method preference and 
gestational age impact woman’s abortion care trajecto-
ries, as certain methods, like surgery, are only available at 
certain facility types.
Table 4 Actual versus preferred first/only abortion 
provider among respondents who reported that they would 
have preferred to use a different provider (N = 255)
Actual source Preferred source
n (%) n (%)
Clinical sources 56 (19.0) 210 (77.4)
Government hospital 12 (4.3) 82 (22.6)
Government health center 5 (2.6) 30 (9.7)
Mobile clinic (public) 0 (0.0) 0 (0.0)
Family planning clinic 0 (0.0) 4 (1.3)
Private hospital 26 (7.6) 76 (37.2)
Private doctor 13 (4.5) 18 (6.7)
Mobile clinic (private) 0 (0.0) 0 (0.0)
Non-clinical sources 199 (81.0) 45 (22.6)
Pharmacy 35 (14.9) 13 (6.6)
Chemist 66 (26.5) 15 (5.9)
Public event 0 (0.0) 0 (0.0)
Fieldworker (private) 2 (1.1) 0 (0.0)
Shop 18 (9.2) 3 (2.1)
Friend/relative 5 (2.2) 1 (0.4)
Healer 23 (7.1) 6 (3.6)
Market 31 (11.5) 3 (1.2)
Other 18 (8.3) 2 (1.1)
Do not know/No response 1 (0.1) 2 (1.8)
Table 5 Reasons why respondents did not use preferred 
provider (N = 255)
Reasons (multiple select) n (%)
Cost 108 (46.1)
Inconvenient 42 (16.0)
Too far 82 (21.9)
Not private 40 (12.9)
Method not available 17 (4.1)
Provider had bad reputation 8 (1.5)
Partner encouraged use of other method 30 (10.4)
Family/friend encouraged use of other method 31 (9.1)
Provider refused 9 (3.5)
Provider not available 12 (3.1)
Side effects associated with method 22 (8.8)
Other 8 (5.2)
Table 6 Percent of respondents who did and did not use their 
preferred first/only abortion provider by sociodemographic 
characteristics (N = 1144)
^From time of baseline survey, not time of abortion
Used preferred 
source (n = 889)
Did not use 
preferred source 
(n = 255)
Characteristic n (row %) n (row %) p-value
Age 0.534
 < 15 30 (96.2) 4 (3.8)
15–19 167 (80.1) 48 (19.9)
20–24 235 (81.5) 78 (18.5)
25–29 196 (83.1) 46 (16.9)
30–34 140 (82.9) 36 (17.1)
35–39 71 (77.1) 24 (22.9)
40–44 28 (78.4) 14 (21.6)
45–49 7 (79.5) 2 (20.5)
No response 15 (81.5) 3 (18.5)
Married/cohabiting 0.812
No 364 (82.0) 85 (18.0)
Yes 522 (81.4) 170 (18.6)
Was attending school 0.341
No 663 (82.6) 192 (17.4)
Yes 225 (79.7) 63 (20.3)
Had children 0.329
No 412 (83.0) 97 (17.0)
Yes 476 (80.5) 158 (19.5)
Wealth^ 0.153
Poorest 126 (79.4) 44 (20.6)
Second poorest 187 (74.5) 73 (25.6)
Middle 168 (84.5) 44 (15.5)
Second wealthiest 209 (84.0) 52 (16.0)
Wealthiest 196 (84.0) 41 (16.0)
Residence 0.629
Rural 341 (80.8) 105 (19.2)
Urban 548 (82.3) 150 (17.7)
State^ 0.026
Anambra 144 (78.6) 47 (21.4)
Kaduna 129 (70.0) 85 (30.0)
Lagos 202 (85.0) 36 (15.0)
Nasarawa 138 (85.3) 27 (14.7)
Rivers 231 (84.6) 42 (15.2)
Taraba 45 (71.1) 18 (28.9)
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Our study has some limitations, including the risk of 
differential underreporting of abortion by provider/loca-
tion, which would bias our observed findings. However, 
we do not think this bias would qualitatively change 
our overall conclusions that a significant proportion 
of women prefer a clinical provider but seek care from 
a non-clinical provider due to financial constraints. 
Another limitation is the potential misclassification of 
abortion provider/location, as some women are reporting 
their abortion experience several years after it took place 
and could be conflating different abortion events. While 
focusing on personal preference and decision-making 
factors, this analysis does not explore all the reasons why 
a woman may opt to go to a certain provider, such as 
gestational age. In addition, women go through different 
pathways to obtain an abortion, not all of which are com-
plete with one visit to one particular provider.
This study also has a number of key strengths. The 
use of a large, population-based survey and the follow-
up survey allowed for more detailed questions about 
the woman’s abortion experience from a large sample 
of women. The use of a population-based survey also 
allowed us to capture the population of women seeking 
abortion care from both formal and informal healthcare 
settings, which provides a more representative range of 
abortion experiences and preferences in Nigeria. The 
findings provide important insight regarding factors 
that would need to be addressed to better meet women’s 
abortion care needs.
Conclusions
These findings add to the literature on women’s abortion 
trajectories, associated decision-making, and barriers to 
care, highlighting the diversity of experiences and pro-
vider preferences, and the need for an expansion of legal, 
low-cost abortion services in clinical healthcare settings 
to better meet women’s reproductive healthcare needs. 
In the meantime, harm reduction efforts should seek 
to increase awareness of medication abortion drugs to 
reduce women’s reliance on non-recommended abortion 
methods, regardless of provider. Additionally, continued 
expansion of voluntary family planning services to pre-
vent unintended pregnancy and increased availability of 
quality PAC services can help decrease unsafe abortion 
related morbidity and mortality.
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